EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of a new tampon device for cytologic autocollection and mass screening of cervical cancer and its precursors


American Journal of Obstetrics & Gynecology 151(3): 351-355
Evaluation of a new tampon device for cytologic autocollection and mass screening of cervical cancer and its precursors
A new autocollection tampon device for obtaining material for cervical cytologic testing was compared with cervical scraping and endocervical aspiration to evaluate the cytodiagnostic results. In 1428 cases there proved to be a 94% correlation between these methods. In addition, both smears were compared in a group of patients known to have neoplastic disease of the cervix. In evaluating cervical cancer both techniques detected 100% of the cases. The smears, both regular and tampon, were able to diagnose only 96.5% and 89% of grade 3 lesions and 86% and 81% of grades 1 and 2 lesions, respectively. False negative results occurred in 8.2% of the regular smears and 15% of the tampon smear group. These preliminary data, if confirmed by more broad and in-depth studies, suggest the new autocollection tampon may be a useful tool for mass cervical screening.

Accession: 005395446

PMID: 3970103

DOI: 10.1016/0002-9378(85)90302-3

Download PDF Full Text: Evaluation of a new tampon device for cytologic autocollection and mass screening of cervical cancer and its precursors



Related references

Cervical cancer screening using the my pap device a self administered vaginal irrigation cytologic test. Laboratory Investigation 64(1): 27A, 1991

Evaluation of the effectiveness of cytologic screening for cervical cancer. II. Survival parameters before and after inception of screening. Mayo Clinic Proceedings 47(8): 545-549, 1972

Evaluation of the effectiveness of cytologic screening for cervical cancer. I. Incidence and mortality trends in relation to screening. Mayo Clinic Proceedings 47(8): 534-544, 1972

Evaluation of the effectiveness of cytologic screening for cervical cancer part 2 survival parameters before and after inception of screening. Mayo Clinic Proceedings 47(8): 545-549, 1972

Evaluation of the effectiveness of cytologic screening for cervical cancer part 1 incidence and mortality trends in relation to screening. Mayo Clinic Proceedings 47(8): 534-544, 1972

Evaluation of a cytologic cervical cancer screening program. Journal of the Kentucky Medical Association 85(2): 75-77, 1987

Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. American Journal of Obstetrics and Gynecology 199(1): 26.E1-8, 2008

Evaluation of the effectiveness of cytologic screening for cervical cancer. 3. Cost-benefit analysis. Mayo Clinic Proceedings 47(8): 550-555, 1972

Changing cytologic detection rates for cervical intraepithelial neoplasia and invasive cancer in a population lacking a mass screening program. Acta Cytologica 33(6): 839-842, 1989

A study of the detection-tampon method as a screening device for uterine cancer. Cancer 10(2): 332-337, 1957